Search Results for "Ondansetron Im"

13:52 EDT 25th June 2016 | BioPortfolio

Matching Channels


Matching News

FDA Drug Safety Communication: Updated information on 32 mg intravenous ondansetron (Zofran) dose and pre-mixed ondansetron products

The U.S. Food and Drug Administration (FDA) is notifying health care professionals that the 32 mg, single intravenous (IV) dose of the antinausea drug Zofran (ondansetron hydrochloride) will no longer...

Ondansetron Should Not Be First Choice for Nausea in Pregnancy

Ondansetron was associated with a low risk for birth defects in neonates who were exposed during the first trimester of pregnancy, and the incidence of cardiac malformations may be increased slightly....

Dexamethasone vs Ondansetron for Postop Nausea and Vomiting

Is dexamethasone as safe and effective as ondansetron in preventing postoperative nausea and vomiting in patients undergoing laparoscopic surgery? BMC Anesthesiology

Bekinda Ondansetron: Phase II started

Ondansetron for Pregnancy-Associated Nausea and Vomiting

First-trimester use seems safe, although data are still limited.

Better Delivery, PTV News: Mar 26, 2010

BioAlliance gets approval to market Ondansetron RapidFilm

Galena Biopharma to Sell Zuplenz® (ondansetron) Oral Soluble Film, Completing Divestiture of Commercial Operations

SAN RAMON, Calif., Dec. 18, 2015 (GLOBE NEWSWIRE) -- Galena Biopharma, Inc. (NASDAQ:GALE), a biopharmaceutical company committed to the development and commercialization of targeted oncology th...

Midatech launches chemo side effect drug in the US

Drug delivery specialist Midatech (LON:MPTH) will commercially launch Zuplenz, its anti-vomiting drug for chemo and radiotherapy patients, in the US this week. Midatech acquired the treatment from G...

Matching PubMed Articles

Effect of Intravenous Ondansetron on the QT Interval of Patients' Electrocardiograms.

Ondansetron improves the success of oral rehydration in children with gastroenteritis. In postoperative adults, ondansetron has been shown to prolong the corrected QT (QTc). The aim of the study was t...

Dexamethasone versus ondansetron in the prevention of postoperative nausea and vomiting in patients undergoing laparoscopic surgery: a meta-analysis of randomized controlled trials.

Dexamethasone is an antiemetic alternative to ondansetron. We aimed to compare the effects of dexamethasone and ondansetron in preventing postoperative nausea and vomiting (PONV) in patients undergoin...

Intravenous Ondansetron and the QT Interval in Adult Emergency Department Patients: An Observational Study.

Ondansetron is known to cause QT interval prolongation, but this effect and clinical significance has not been prospectively studied in adult emergency department (ED) patients. The primary objective ...

Comparing the Antiemetic Effects of Ondansetron and Metoclopramide in Patients with Minor Head Trauma.

Nausea and vomiting are the most common complications after minor head trauma that increases the risk of intracranial pressure rising. Therefore, the present study was aimed to compare the antiemetic ...

Effects of Preoperative Serotonin-Receptor-Antagonist Administration in Spinal Anesthesia-Induced Hypotension: A Randomized, Double-blind Comparison Study of Ramosetron and Ondansetron.

The adverse effects of spinal anesthesia (SA) include arterial hypotension and bradycardia. The aim of this study was to compare the effects of 2 type 3 serotonin receptor antagonists in SA-induced ad...

Search Whole site using Google

Quick Search
Advertisement Advertisement